SEOUL, South Korea, May 29, 2025 /PRNewswire/ -- Nextbiomedical announced today that its novel hemostatic powder, Nexpowder™, has been published in GUT (Impact Factor: 23), one of the world's most ...
LS Securities forecasted on the 22nd that sales of Nextbiomedical will rapidly increase as the market penetration rate of NexPowder rises. Jo Eun-ae, a researcher at LS Securities, explained, ...
Next Biomedical announced on the 17th that it has completed the first shipment of its hemostatic agent for endoscopy, Nexpowder, to Japan. Nexpowder received product approval from the Pharmaceuticals ...
The US Food and Drug Administration has cleared the Nexpowder endoscopic hemostasis system. Nexpowder (Medtronic) uses a noncontact, nonthermal, nontraumatic hemostatic powder that is sprayed through ...
The Nexpowder system includes a hand-held spray controller that connects to a catheter. Once the bright blue powder is sprayed onto a bleeding site, it reacts with the blood to form a gel with nearly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results